|
|
|
Insider
Information: |
Malik Fady Ibraham |
Relationship: |
EVP Research & Develop... |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
135,004 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$7,280,766 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
135,004 |
|
|
Total
Value |
$7,280,766 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.5
|
Percentage
Gain/Loss : |
0.0%
|
322.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Cytokinetics Inc |
CYTK |
EVP Research & Develop... |
2024-06-11 |
135,004 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
120 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2021-02-26 |
4 |
D |
$18.73 |
$132,234 |
D/D |
(7,060) |
141,749 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2021-03-01 |
4 |
D |
$19.66 |
$54,399 |
D/D |
(2,767) |
138,982 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2021-03-08 |
4 |
D |
$19.19 |
$146,496 |
D/D |
(7,634) |
166,348 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2022-02-28 |
4 |
D |
$35.32 |
$122,137 |
D/D |
(3,458) |
153,004 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2022-03-02 |
4 |
D |
$37.63 |
$188,301 |
D/D |
(5,004) |
148,000 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2022-03-07 |
4 |
D |
$36.83 |
$365,206 |
D/D |
(9,916) |
168,084 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2023-02-16 |
4 |
D |
$44.13 |
$66,769 |
D/D |
(1,513) |
150,926 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2023-03-02 |
4 |
D |
$39.60 |
$427,086 |
D/D |
(10,785) |
140,141 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2023-03-06 |
4 |
D |
$39.13 |
$194,007 |
D/D |
(4,958) |
135,183 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-03-04 |
4 |
D |
$67.68 |
$651,758 |
D/D |
(9,630) |
133,343 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-03-06 |
4 |
D |
$66.88 |
$542,330 |
D/D |
(8,109) |
121,234 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2023-02-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
152,439 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-04-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
138,417 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
SVP Research & Early DevOffice |
|
2012-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
33,632 |
|
- |
|
CYTK |
Cytokinetics Inc |
SVP Research & Early Dev |
|
2012-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,500 |
121,132 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
SVP Research & Early Dev |
|
2013-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,583 |
29,846 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2017-11-01 |
4 |
OE |
$11.10 |
$73,993 |
D/D |
6,666 |
52,234 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2021-01-14 |
4 |
OE |
$9.42 |
$117,750 |
D/D |
12,500 |
162,324 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2021-12-09 |
4 |
OE |
$6.30 |
$183,746 |
D/D |
29,166 |
172,053 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2022-03-10 |
4 |
OE |
$6.00 |
$161,112 |
D/D |
26,852 |
194,936 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2022-04-07 |
4 |
OE |
$6.00 |
$138,888 |
D/D |
23,148 |
191,232 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2022-05-12 |
4 |
OE |
$9.65 |
$134,975 |
D/D |
13,987 |
182,071 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2022-06-09 |
4 |
OE |
$9.65 |
$207,475 |
D/D |
21,500 |
189,846 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2022-07-14 |
4 |
OE |
$9.65 |
$207,475 |
D/D |
21,500 |
189,846 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2022-09-08 |
4 |
OE |
$9.65 |
$207,475 |
D/D |
21,500 |
189,846 |
0 |
- |
|
120 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|